Matrix Metalloproteinase 9 (MMP-9), also known as gelatinase B, is a critical enzyme in the human body that plays a vital role in remodeling the extracellular matrix, the network of proteins and other substances surrounding cells. It belongs to a larger family of enzymes known as matrix metalloproteinases, which are responsible for breaking down various components of the extracellular matrix.
MMP-9 specifically targets collagen and gelatin, important structural proteins in tissues. By breaking down these proteins, MMP-9 aids in processes like wound healing, tissue repair, and angiogenesis (the formation of new blood vessels). This makes it an essential player in normal physiological processes. However, MMP-9's activity isn't always beneficial; its overactivity or dysregulation is linked to various diseases.
Elevated levels of MMP-9 have been associated with inflammatory diseases, such as arthritis, where it contributes to the breakdown of joint tissues. It's also implicated in cancer, as its ability to remodel the extracellular matrix can aid in tumor growth and the spread of cancer cells. In heart disease, MMP-9 can weaken blood vessel walls, contributing to conditions like aneurysms.
In response to its significant role in various diseases, MMP-9 has become a target for drug development. Researchers are exploring ways to inhibit its activity to treat conditions where its overactivity causes harm.
References:
Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda). 2013 Nov;28(6):391-403. doi: 10.1152/physiol.00029.2013. PMID: 24186934; PMCID: PMC3858212.
Huang H. Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors (Basel). 2018 Sep 27;18(10):3249. doi: 10.3390/s18103249. PMID: 30262739; PMCID: PMC6211011.
Seitz-Holland, J., Seethaler, M., Makris, N. et al. The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study. Neuropsychopharmacol. 47, 524–530 (2022). https://doi.org/10.1038/s41386-021-00997-5
Kim, WU., Min, SY., Cho, ML. et al. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Res Ther 7, R71 (2004). https://doi.org/10.1186/ar1454
Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression, Front. Neurol., 18 March 2022 Sec. Neurological Biomarkers Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.861843
Links:
https://www.labcorp.com/tests/500124/mmp-9-matrix-metalloproteinase-9
https://ltd.aruplab.com/Tests/Pub/3005003
https://mlabs.umich.edu/tests/matrix-metalloproteinase-9-mmp-9
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.